Skip to main content
Log in

The results of HbA1c measurement and its comparison with reference method values in an EQA programme

  • Practitioner's Report
  • Published:
Accreditation and Quality Assurance Aims and scope Submit manuscript

Abstract

This article describes the effect of a change in reference method for HbA1c measurement on results in our EQA programme. Important indicators of analytical quality, particularly reproducibility, bias and uncertainty, were assessed. Basic analytical quality indicators for the measurement of HbA1c in an EQA survey during 2000–2008 were evaluated. Three EQA surveys per year were performed. Usually there were more than 200 participating laboratories in each survey. Reproducibility, systematic differences, bias, and methodology changes before and after IFCC reference method implementation were determined. In the EQA surveys, target values traceable to the IFCC reference method are used. Estimation of the combined uncertainty of the result was a voluntary part of the surveys and was reported by 50% of participating laboratories. Reproducibility of all participants’ measurements was close to the target value of CV = 5.0% (coefficient of variation). The group of participants using HPLC methodology had reproducibility lower than 5.0% in each survey, whilst the immunochemistry group usually had CV values more than 6.0%. The differences in individual results from target values ranged in the interval ±12% for HPLC methods but more (−8 to +30%) for immunochemistry methods. During the monitored time interval the number of participants using HPLC methods increased up to 70% whilst the number of participants using immunochemistry methods decreased approximately to 30%. The combined uncertainty (u c ) reported by participants varies between 4.0 and 4.5% for HbA1c values between 30 and 90 mmol/mol. No significant differences between precision and systematic errors (bias) after the implementation of IFCC method of measurement for HbA1c to routine processes for HPLC were observed. Immunochemical methods do not fulfil requirements for analytical reproducibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Mosca A, Goodall I, Hostino T, Jeppsson JO, Garry John W, Little RR et al (2007) Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 45:1077–1080

    Article  CAS  Google Scholar 

  2. Little R, Rohlfing CL, Wiedmayer MM, Myers GL, Sacks DB, Goldstein DE (2001) The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 47:1985–1992

    CAS  Google Scholar 

  3. Sacks DB for the ADA/EASD/IDF Working Group for the HbA1c. (2005) Clin Chem 51:681-683

    Google Scholar 

  4. Jeppsson J-O, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mauri P, Mosca A, Paroni R, Thienpont L, Umemoto M, Weykamp CW (2002) Approved IFCC reference method for the of HbA1c in human blood. Clin Chem Lab Med 40:78–89

    Article  CAS  Google Scholar 

  5. Nordin G, Dybkaer R (2007) Recommendation for term and measurement unit for “HbA1c”. Clin Chem Lab Med 45:1081–1082

    Article  CAS  Google Scholar 

  6. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM (2004) IFCC Reference System for Measurement of Hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan and Sweden: a method comparison study. Clin Chem 50:166–174

    Article  CAS  Google Scholar 

  7. Geistanger A, Arends S, Berding Ch, Hoshino T, Jeppsson JO, Little R, Carla Siebelder C, Weykamp C (2008) Statistical methods for monitoring the relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan and Sweden. Clin Chem 54:1379–1385

    Article  CAS  Google Scholar 

  8. Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson JO, Goodall I, Miedema C, Myers G, Reinauer H, Sacks DB, Slingerland R, Siebelder C (2008) The IFCC Reference Measurement System for HbA1c: a 6-year progress report. Clin Chem 54:240–248

    Article  CAS  Google Scholar 

  9. Annesley T (2009) Mass spectrometry in the clinical laboratory: how have we done and where do the need to be. Clin Chem 55:1236–1239

    Article  Google Scholar 

  10. Implementation of standardization of HbA1c measurement. Condensed summary of the meeting with manufacturers held in Milan, Italy, December 12, 2007 (2008) Clin Chem 54:1098–1099

  11. International expert committee report on the role of the A1C assay in the diagnosis of diabetes (2009) Diabetes Care 32:1–8

    Article  Google Scholar 

  12. Sacks DB (2009) The diagnosis of diabetes is changing: how implementation of hemoglobin A1c will impact clinical laboratories. Clin Chem 55:1612–1614

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ilona Šperlingová.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedecký, B., Kratochvíla, J., Budina, M. et al. The results of HbA1c measurement and its comparison with reference method values in an EQA programme. Accred Qual Assur 15, 239–243 (2010). https://doi.org/10.1007/s00769-009-0626-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00769-009-0626-4

Keywords

Navigation